Filtered By:
Condition: Bleeding
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 57721 results found since Jan 2013.
Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):467-473. doi: 10.1182/hematology.2022000401.ABSTRACTEstrogen exposure, in the setting of pregnancy, the postpartum state, combined hormonal contraceptives (CHCs), or hormone therapy use, has been clearly associated with increased rates of venous thromboembolism (VTE). Although recurrence rates are low in these settings, up to 70% of anticoagulated menstruating individuals experience abnormal or heavy menstrual bleeding (HMB), which commonly results in iron deficiency with or without anemia. Patients taking rivaroxaban appear to experience higher rates of HMB compar...
Source: Hematology ASH Education Program - December 9, 2022 Category: Hematology Authors: Emma DeLoughery Bethany Samuelson Bannow Source Type: research
